Publicação: Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
Objectives: To examine the effects of triiodothyronine (T3), 17β-estradiol (E2), and tamoxifen (TAM) on transforming growth factor (TGF)-α gene expression in primary breast cancer cell cultures and interactions between the different treatments. Methods and results: Patients included in the study (no.=12) had been newly diagnosed with breast cancer. Fresh human breast carcinoma tissue was cut into 0.3-mm slices. These slices were placed in six 35-mm dishes on 2-ml organ culture medium. Dishes received the following treatments: dish 1: ethanol; dish 2: T3; dish 3: T3+TAM; dish 4: TAM; dish 5: E2; dish 6: E2+TAM. TGF-α mRNA content was normalized to glyceraldehyde-3-phosphate dehydrogenase mRNA levels. All tissues included in this study were positive for estrogen receptor (ER) and thyroid hormone receptor expression. Treatment with T3 for 48 h significantly increased TGF-α mRNA levels compared to controls (15-fold), and concomitant treatment with TAM reduced expression to 3.4-fold compared to controls. When only TAM was added to the culture medium, TGF-α mRNA expression increased 5.3-fold, significantly higher than with all other treatment modalities. Conclusion: We demonstrate that TGF-α mRNA expression is more efficiently upregulated by T3 than E2. Concomitant treatment with TAM had a mitigating effect on the T3 effect, while E2 induced TGF-α upregulation. Our findings show some similarities between primary culture and breast cancer cell lines, but also some important differences: a) induction of TGF-α, a mitogenic protein, by TAM; b) a differential effect of TAM that may depend on relative expression of ER α and β; and c) supraphysiological doses of T3 may induce mitogenic signals in breast cancer tissue under conditions of low circulating E2. ©2008, Editrice Kurtis.
Descrição
Palavras-chave
Breast cancer samples, Estrogen, Tamoxifen, TGF-α, Triiodothyronine, cyclin D1, estradiol, estrogen receptor alpha, estrogen receptor beta, glyceraldehyde 3 phosphate dehydrogenase, liothyronine, messenger RNA, tamoxifen, thyroid hormone receptor, transforming growth factor alpha, adult, aged, breast carcinoma, cancer cell culture, clinical article, controlled study, culture medium, drug mechanism, female, gene expression regulation, human, human cell, human tissue, mitogenicity, upregulation, Adult, Aged, Aged, 80 and over, Breast Neoplasms, Carcinoma, Cell Culture Techniques, Down-Regulation, Drug Interactions, Estradiol, Female, Gene Expression Regulation, Neoplastic, Humans, Middle Aged, Transforming Growth Factor alpha, Tumor Cells, Cultured
Idioma
Inglês
Como citar
Journal of Endocrinological Investigation, v. 31, n. 12, p. 1047-1051, 2008.
